Elham Abboud, MD
Anatomic Pathology & Clinical Pathology · Chicago, ILNPI 1164409447
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. 2024 is the largest year on record at $777, 2.2 times the $360 reported in 2019. Among anatomic pathology & clinical pathology clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 91 payments — averaging $21.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$328
- Novartis$291
- Foundation Medicine, Inc.$269
- Lilly USA, LLC$256
- Johnson & Johnson$133
- Pfizer$122
- plus $522 from 13 others
What the payments were for
- Food & beverage$1,921100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 14 | $328 |
| Novartis | 15 | $291 |
| Foundation Medicine, Inc. | 15 | $269 |
| Lilly USA, LLC | 11 | $256 |
| Johnson & Johnson(2 entities) | 6 | $133 |
| Pfizer | 6 | $122 |
| Daiichi Sankyo Inc. | 3 | $76 |
| Eisai Inc. | 3 | $71 |
| Springworks Therapeutics, Inc. | 2 | $69 |
| Astellas Pharma US Inc | 2 | $47 |
| Blueprint Medicines Corporation | 2 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $45 |
| Ortho-clinical Diagnostics, Inc. | 3 | $44 |
| Cumberland Pharmaceuticals, Inc. | 2 | $30 |
| Seagen Inc. | 1 | $25 |
| Cepheid | 1 | $19 |
| Siemens Medical Solutions USA, Inc. | 1 | $17 |
| Medline Industries LP | 1 | $16 |
| Exelixis Inc. | 1 | $15 |
How this compares
$1,921 in reported general payments places this provider in the 90th percentile of 331 anatomic pathology & clinical pathology providers in Illinois.
See all anatomic pathology & clinical pathology providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anatomic pathology & clinical pathology in Chicago
- Jeffrey MuellerChicago$71K
- Lindsay AlpertChicago$57K
- Daniel ArberChicago$37K
- Kalliopi SiziopikouChicago$18K
- Namrata SetiaChicago$15K
- Carlos GarciaChicago$8K
- Ricardo LastraChicago$8K
- Melissa TjotaChicago$5K
- Mark PoolChicago$4K
- Behtash NezamiChicago$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.